Learn bits
Health & Medicine, Schemes & Policies
Mahesh

12/07/22 05:46 AM IST

Strengthening of Pharmaceutical Industry (SPI)

In News 
  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers has released the guidelines for the scheme Strengthening of Pharmaceutical Industry (SPI)"with a total financial outlay of Rs.500 Cr for the period from FY 21-22 to FY 25-26. 
Features of the Scheme 
  • The scheme will address the rising demand in terms of support required to existing Pharma clusters and MSMEs across the country to improve their productivity, quality and sustainability.
  • The objectives of the scheme “Strengthening of Pharmaceutical Industry (SPI) are to strengthen the existing infrastructure facilities in order to make India a global leader in the Pharma Sector. Under the Scheme, financial assistance to pharma clusters will be provided for creation of Common Facilities.
  • This will not only improve the quality but also ensure the sustainable growth of clusters.
  • Further, in order to upgrade the production facilities of SMEs and MSMEs so as to meet national and international regulatory standards (WHO-GMP or Schedule-M), interest subvention or capital subsidy on their capital loans will be provided, which will further facilitate the growth in volumes as well as in quality.
  • The Scheme has 3 components / sub-schemes: Assistance to Pharmaceutical Industry for Common Facilities (APICF), to strengthen the existing pharmaceutical clusters’ capacity for their sustained growth by creating common facilities;
  • Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) to facilitate Micro, Small and Medium Pharma Enterprises (MSMEs) of proven track record to meet national and
  • International regulatory standards and Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS) to facilitate growth and development of Pharmaceutical and Medical Devices Sectors through study/survey reports, awareness programs, creation of database, and promotion of industry.
Other schemes related to pharma:
  • Promotion of Bulk Drug Parks Scheme: To develop 3 mega Bulk Drug parks in India
  • Production Linked Incentive (PLI) Scheme: To promote domestic manufacturing of critical Key Starting Materials (KSM) and Active Pharmaceutical Ingredients (APIs) in the country.
Source- PIB 

More Related Current Affairs View All

19 Nov

India’s road to net-zero

'Every year, climate action draws significant attention in the months leading up to the United Nations’ annual meeting of the Conference of the Parties (COPs).' An econo

Read More

18 Nov

AFSPA in Manipur

'The Manipur government has formally requested the Centre to reconsider and revoke the reimposition of the Armed Forces (Special Powers) Act (AFSPA) in six police station areas of

Read More

18 Nov

BS-III petrol and BS-IV diesel four-wheelers

'With high levels of pollution in Delhi and smog blanketing the city, the Delhi government has introduced measures to improve the air quality.' The Graded Response Action Plan (

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps